Centering Patient Expectations of a Novel Home-Based Oral Drug Treatment among <i>T. b. rhodesiense</i> Human African Trypanosomiasis Patients in Uganda
The recent approval of fexinidazole for human African trypanosomiasis (HAT) caused by <i>T. b. gambiense</i> enables improved patient management that is pivotal to elimination. Effective in both the early and late stages of the disease, it obviates the need for invasive lumbar punctures...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-01-01
|
| Series: | Tropical Medicine and Infectious Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2414-6366/5/1/16 |